Masimo (MASI)
(Delayed Data from NSDQ)
$125.46 USD
+0.66 (0.53%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $125.53 +0.07 (0.06%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth F Momentum D VGM
Brokerage Reports
Masimo Corporation [MASI]
Reports for Purchase
Showing records 381 - 400 ( 484 total )
Company: Masimo Corporation
Industry: Medical - Instruments
Positive Start to Year, Like the Risk- Reward Profile; Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Healthcare - 1Q 2013: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Q4 results roughly in-line net of FX, 2013 EPS guidance below consensus, reducing PT
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Masimo Corporation
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
Good 4Q, Mixed Guidance; Positive Long-Term Thesis; Buy
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Preview: 4Q Toward Low-end, Rainbow Below Guidance; Risk/Reward Still Favorable
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Healthcare -4Q 2012: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
Updating Model for Device Tax, Introducing 2014; Good Idea for Next Year
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Q3 revenue and EPS slightly below expectations, guidance reiterated
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
Looking Up for Rainbow - Consistent Outlook; Maintain Buy
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M